Global Medical Imaging Reagents Market by Products, Applications, Growth Trends and Forecast to 2021, New Report by iHealthcareAnalyst, Inc.
Medical Imaging Reagents Market by Product Type (Contrast Reagents, Optical Reagents, Nuclear Reagents), Technology (Fluorescent Dyes and Probes, Fluorescent Proteins, Nanoparticles, Quantum Dots, Radiopharmaceuticals), and Applications (Diagnostics, Drug Discovery and Development, Research and Development) and Forecast 2017-2021.
Maryland Heights, MO, April 08, 2017 --(PR.com)-- The global medical imaging reagents market is estimated to reach US$ 21.5 Bn in 2021, expanding at a CAGR of 8.5% from 2017 to 2021.
Browse Medical Imaging Reagents Market by Product Type (Contrast Reagents, Optical Reagents, Nuclear Reagents), Technology (Fluorescent Dyes and Probes, Fluorescent Proteins, Nanoparticles, Quantum Dots, Radiopharmaceuticals), and Applications (Diagnostics, Drug Discovery and Development, Research and Development) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/medical-imaging-reagents-market/
Medical imaging reagents are chemicals to allow clinicians to improve the imaging of specific organs, tissues, diseases and physiological functions. Medical imaging reagents are specially designed chemical compounds used to enhance images produced through imaging systems. These reagents allow clinicians and healthcare providers to determine whether a tumor is malignant or benign and enables to locate any metastatic cancerous sites in the body. Medical imaging reagents are used for diagnosing disease, monitoring disease progression, tracking therapeutic response, and enhancing our knowledge of physiology and pathophysiology. Medical imaging incorporates radiology which uses the imaging technologies of X-ray radiography, magnetic resonance imaging, medical ultrasonography or ultrasound, endoscopy, elastography, tactile imaging, thermography, medical photography and nuclear medicine functional imaging techniques as positron emission tomography (PET) and Single-photon emission computed tomography (SPECT). Medical imaging reagents play a significant role in diagnostic, pharmaceuticals, biotechnology medical and life science industries.
The global medical imaging reagents market segmentation is based on product types (contrast reagents, optical reagents, nuclear reagents), technology (fluorescent dyes and probes, fluorescent proteins, nanoparticles, quantum dots, radiopharmaceuticals), and applications (diagnostics, drug discovery and development, research and development).
The global medical imaging reagents market report provides market size (Revenue US$ Mn 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global medical imaging reagents market research report is further segmented by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global medical imaging reagents market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
Major players operating in the global medical imaging reagents market and included in this report are Bayer Healthcare AG, Bracco Imaging SpA, GE Healthcare, Lantheus Medical Imaging, Inc., Mallinckrodt Pharmaceuticals, Siemens Healthcare, Thermo Fisher Scientific, Inc. and others.
To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/medical-imaging-reagents-market/
About Us
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com
Browse Medical Imaging Reagents Market by Product Type (Contrast Reagents, Optical Reagents, Nuclear Reagents), Technology (Fluorescent Dyes and Probes, Fluorescent Proteins, Nanoparticles, Quantum Dots, Radiopharmaceuticals), and Applications (Diagnostics, Drug Discovery and Development, Research and Development) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/medical-imaging-reagents-market/
Medical imaging reagents are chemicals to allow clinicians to improve the imaging of specific organs, tissues, diseases and physiological functions. Medical imaging reagents are specially designed chemical compounds used to enhance images produced through imaging systems. These reagents allow clinicians and healthcare providers to determine whether a tumor is malignant or benign and enables to locate any metastatic cancerous sites in the body. Medical imaging reagents are used for diagnosing disease, monitoring disease progression, tracking therapeutic response, and enhancing our knowledge of physiology and pathophysiology. Medical imaging incorporates radiology which uses the imaging technologies of X-ray radiography, magnetic resonance imaging, medical ultrasonography or ultrasound, endoscopy, elastography, tactile imaging, thermography, medical photography and nuclear medicine functional imaging techniques as positron emission tomography (PET) and Single-photon emission computed tomography (SPECT). Medical imaging reagents play a significant role in diagnostic, pharmaceuticals, biotechnology medical and life science industries.
The global medical imaging reagents market segmentation is based on product types (contrast reagents, optical reagents, nuclear reagents), technology (fluorescent dyes and probes, fluorescent proteins, nanoparticles, quantum dots, radiopharmaceuticals), and applications (diagnostics, drug discovery and development, research and development).
The global medical imaging reagents market report provides market size (Revenue US$ Mn 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global medical imaging reagents market research report is further segmented by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global medical imaging reagents market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
Major players operating in the global medical imaging reagents market and included in this report are Bayer Healthcare AG, Bracco Imaging SpA, GE Healthcare, Lantheus Medical Imaging, Inc., Mallinckrodt Pharmaceuticals, Siemens Healthcare, Thermo Fisher Scientific, Inc. and others.
To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/medical-imaging-reagents-market/
About Us
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com
Contact
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 500-7508
https://www.ihealthcareanalyst.com/
Ana Aitawa
(314) 500-7508
https://www.ihealthcareanalyst.com/
Contact
Categories